跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,986 条关于
“Kali Therapeutics”
全部
16,986
临床试验
3,838
药物
3,158
机构
1,155
资讯
8,835
6个月前
Sanofi Commits $180M for Kali's Novel Trispecific Antibody in Autoimmune Disease Partnership
上个月
Trispecific Antibodies: The Next Frontier in Immunotherapy Gains Momentum with Big Pharma Investments
3个月前
Flexible Trial Execution: Blending Site-Based and At-Home Models Without Compromising Quality — Upcoming Xtalks Webinar
10个月前
SparingVision Initiates First-in-Human Trial of Gene-Agnostic Therapy SPVN20 for Advanced Retinitis Pigmentosa
7个月前
SparingVision Completes Dosing in Phase I/II Trial for Gene-Agnostic Retinitis Pigmentosa Therapy SPVN06
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
3个月前
XRHealth Acquires Swing Therapeutics to Expand Digital Therapeutics Portfolio
去年
Valerio Therapeutics Expands Antibody Development Capabilities with Emglev Therapeutics Acquisition
4年前
Rise Therapeutics Advances Oral Immunotherapies Across Multiple Phase 1 Trials
去年
Sapience Therapeutics Advances ST316 into Phase 2 Trial for Advanced Solid Tumors
第 1 页,共 884 页
上一页
下一页